Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.00
Bid: 143.80
Ask: 144.60
Change: -1.20 (-0.83%)
Spread: 0.80 (0.556%)
Open: 149.80
High: 149.80
Low: 143.20
Prev. Close: 145.20
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM / Interim Management Statement

21 Apr 2011 07:00

RNS Number : 3174F
Elementis PLC
21 April 2011
 



21 April 2011

 

AGM / Interim Management Statement

Elementis plc ("the Company") today issues its Interim Management Statement for the three months ended 31 March 2011 in relation to the Company and its subsidiaries ("the Group").

 

Trading for the first three months of the year is significantly ahead of the same period last year due to strong demand in our key end markets and improved margins in all businesses. Our order book remains strong with robust demand continuing into the second quarter. As a result, Group earnings for the full year are expected to be at the upper end of market expectations.

 

In Specialty Products, sales in the first quarter were 9 per cent ahead of the same period last year, which is particularly notable given that the first quarter of 2010 was positively impacted by heavy customer restocking in coatings.

 

·; Sales of coatings additives have continued to grow in all geographies with underlying demand being enhanced by product innovation and market share gains. In North America signs of economic recovery helped drive an improvement in coatings sales of 12 per cent over the same period last year, while Europe and Asia Pacific recorded gains of 9 per cent and 7 per cent respectively.

·; Personal care continued to benefit from the product optimisation exercise undertaken as part of the integration of Fancor, leading to lower sales volumes but improved margins and profitability.

·; Sales to the oilfield drilling sector have also continued to show the strong growth trend exhibited throughout 2010 with an increase of 15 per cent, driven by the expansion in shale gas activity and a strong drilling season in Canada.

 

Operating margins in Specialty Products continued to improve due to growth in higher margin products and ongoing pricing initiatives. Consequently operating margins are significantly ahead of those experienced in the second half of 2010.

 

Our Chromium business has continued to operate at consistently high rates of capacity utilisation during the first three months of the year, sustaining sales volumes at the levels seen during the same period last year. Global demand for chromium products has continued to be robust and this is allowing the business to optimise its production and to increase the proportion of its sales into the more differentiated North American market. At the same time raw material cost increases have been successfully passed on through pricing initiatives. Consequently operating margins are slightly ahead of the second half of 2010. Going forward margins will benefit from the completion, during the second quarter, of the flexible energy project at the main US facility. This will allow the use of natural gas as well as fuel oil as the facility's energy source, with a consequent cost saving for the balance of the year of approximately $4 million.

 

The strong sales growth and low capital intensity of the Group's businesses is continuing to generate positive cash flow, leading to further reductions in debt levels.

 

Enquiries:

 

Elementis plc

020 7408 9300

Brian Taylorson, Finance Director

Financial Dynamics

020 7831 3113

Greg Quine

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMGZDMGDGMZZ
Date   Source Headline
30th May 202412:52 pmRNSDirector/PDMR Shareholding
29th May 20241:07 pmRNSDirector Declaration
8th May 202411:08 amRNSDirector/PDMR Shareholding
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.